OQROGet OQRO Pro
Insider trade

Ars Pharmaceuticals (SPRY)Chief Commercial Officer sold ~$240K

Eric Karas, Chief Commercial Officer at Ars Pharmaceuticals, sold ~$240K of Ars Pharmaceuticals shares.

~$240K
Approx. value · 15K sh @ $16.00
7,696
Holds after · shares reported
Traded
Jun 18, 2025
Filed
Jun 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 20, 2025Insider · 3 peopleInsiders: 3 sales (~$3.9M)
  2. Jun 18, 2025 · this disclosureInsiderOfficer sold ~$240K of SPRY shares in the open market

What came next

  1. Jun 27, 2025Insider · 1 personInsiders: 2 sales (~$13.7M)
  2. Jul 1, 2025InsiderOfficer sold ~$255K of SPRY shares in the open market
  3. Aug 19, 2025InsiderOfficer sold ~$173K of SPRY shares in the open market
  4. Aug 20, 2025InsiderOfficer sold ~$531K of SPRY shares in the open market
  5. Aug 21, 2025Insider · 2 peopleInsiders: 2 sales (~$912K)
  6. Sep 29, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ars Pharmaceuticals

For Ars Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SPRY page.

Other recent filings by Eric Karas, Chief Commercial Officer

The full history of Eric Karas, Chief Commercial Officer is on the profile page.

How this filing works

Other disclosures at Ars Pharmaceuticals

Everything OQRO holds on this company is on its SPRY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data